Methods. We performed a cross-sectional analysis using data from the 2009 National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS). The NAMCS and NHAMCS survey patient visits to physicians in non-federally funded, non-hospital-based offices and non-federally funded hospital outpatient departments, respectively. 2 We limited our sample to visits by patients to their primary care physicians. Visits for each "top 5" primary care activity were identified using a combination of the patient-described Reason For Visit (RFV) and the physician's diagnosis as coded by the International Classification of Diseases, Ninth Revision, Clinical Modification (Table) . Nonrecommended care ordered during the visit included that defined by the Good Stewardship Working Group (Table) , with some exceptions owing to methodological limitations (unable to identify early referral of otitis media with effusion and appropriate use of corticosteroids based on asthma severity). We excluded from the denominator those visits in which the activity could be considered appropriate.
We calculated each activity as the proportion of eligible visits during which the patient received nonrecommended care. We applied the sampling weights and sample design variables to generate national estimates and 95% confidence intervals using Stata statistical software, version 11.0 (StataCorp, College Station, Texas).
We estimated the costs of procedures using the 2011 Medicare physician fee schedule, and in the case of laboratory tests, the 2011 Medicare Clinical Laboratory Fee Schedule 3 (eTable; http://www.archinternmed.com). We estimated the costs of drugs using common acquisition costs to consumers from drugstore.com 4 or retail pharmacies. 5
Results. We found a wide range of frequencies (1.4%-56.0%) of nonrecommended activities in primary care, accounting for an approximate annual cost of $6.76 billion (95% CI, $5.0-$9.1 billion) (Table) . The ordering of a complete blood cell count for a general medical examination was the most prevalent activity (56.0%, 95% CI, 40.8%-70.2%) and was associated with a cost of $32.7 million (95% CI, $23.9-$40.8 million).
Several practice activities occurred less commonly, such as ordering of bone density testing in women younger than 65 years (1.4%; 95% CI, 0.9%-2.2%) and Papanicolaou tests for patients younger than 21 years (2.9%; 95% CI, 1.7%-5.0%). We were unable to report the performance of dualenergy x-ray absorptiometry scans in men younger than 70 years and imaging for children with head injuries in ambulatory settings owing to their low frequency (visits Ͻ30).
Cost of unnecessary services was a function of both the frequency and the reimbursement rates for each service. The practice activity associated with the highest cost was the prescribing of brand instead of generic statins, resulting in excess expenditures of $5.8 billion per year (95% CI, $4.3-$7.3 billion). Bone density testing in women younger than 65 years was the least prevalent activity but accounted for $527 million (95% CI, $474-$1054 million) in costs.
Comment. Our analysis of outpatient visits demonstrates that there is considerable variability in the frequency of inappropriate care and that many of the activities identified in the Good Stewardship "Top 5" lists 1 have marginal impact on health care costs. Approximately 86% of the costs associated with the "Top 5" lists were from the use of brand name instead of generic statins. Although generic drug substitutions may appear to be a "low hanging fruit" for drug savings, numerous efforts have already been made by the US states (generic substitution laws), payers (tiered formularies), and health care providers (generic drug detailing) to achieve this goal. In this light, our data suggest that considerably more work is needed to reduce the costs associated with brand name statin use. Our results also demonstrate that highly prevalent activities with small individual costs can result in large overall costs to the health care system and thus warrant further attention.
Our analysis is limited by the available data of the NAMCS/NHAMCS data set and by our ability to accurately estimate visits with inappropriate care. We were conservative in our assessment of inappropriate care and were careful to exclude visits where care could be potentially appropriate, likely lowering our cost estimates.
The recent debate surrounding escalating health care costs and the sustainability of Medicare have focused attention on the delivery of high-quality, efficient care. The discussion certainly needs the participation of physicians who are willing to examine their own practices, such as the Good Stewardship Working Group. However, most primary care activities identified by the working group 
Psychological Distress as a Risk Factor for Dementia Death
C urrent estimates suggest that neuropsychiatric disorders account for 28% of the global burden of disease. 1 While depression and anxiety (commonly referred to as psychological distress) have been shown to be a consequence of dementia, the converse is less clear. The possibility that psychological distress might be a risk factor for dementia has major public health implications. However longitudinal studies-which are best placed to examine this relationship-have, with some exceptions, 2,3 been small in scale (affecting study precision), excluded individuals younger than 65 years (limiting insights into the pre-older age origins of dementia), or have used clinical samples (reducing generalizability). Accordingly, we examined the role of psychological distress as a risk factor for and dementia death by pooling 10 large community-based cohort studies.
Methods.
Participants were recruited from the Health Survey for England, 4 an annual general population-based cross-sectional study (with a longitudinal component) representative of household-dwelling individuals in England. Results from 1994 through 2004 were pooled. Participants gave informed consent; ethical approval was obtained from the London Research Ethics Council.
Psychological distress was measured during a household visit using the 12-item General Health Questionnaire (GHQ-12), a widely used measure of psychological distress in population studies comprising items rating anxiety, depression, social dysfunction, and loss of confidence. Higher scores indicate greater distress. We used a cut off score of 4 or greater to denote psychological distress as validated against standardized psychiatric interviews. 5 Dementia was identified from death certification and coded according to the International Classification of Diseases, Ninth Revision (ICD-9) codes 290.0 through 290.4 and 294.9 and International Statistical Classification of Diseases, 10th Revision (ICD-10) codes F01, F03, F09, and G30. Follow-up was until date of death or February 15, 2008, whichever came first.
We used Cox proportional hazards models to compute hazard ratios with accompanying 95% confidence intervals for GHQ-12 score in relation to dementiarelated deaths. Study members scoring zero (no apparent distress) denoted the reference group. Models were adjusted for age, sex, occupational social class (OSC), 6 parental OSC, age at leaving full-time education, current smoking (yes/no), alcohol consumption (units per week), and existing cardiovascular disease (CVD) (yes/ no), and diabetes (yes/no). Statistical analyses were conducted using PASW statistics, version 18.0 (SPSS, Chicago, Illinois), and R for Max OS X, version R-2.13.0.
Results. The initial sample included 85 261 adults (in 1996 the GHQ-12 was not used). After removing individuals who declined linkage to mortality records (n=9325) and those with missing GHQ-12 data (n=2865), the analytic sample comprised 73 071 individuals (54.8% women) with a mean (SD) age of 55.9 (14.3) years (range, 35-102 years). Data were missing for 1 or more variables in 21% (n=15 355) of the sample. Individuals with missing data were more likely to be older, be female, belong to a manual OSC, leave school later, be a nonsmoker, drink alcohol moderately, and have CVD and diabetes.
Of the 10 170 deaths during follow-up, 455 had dementia coding. A higher GHQ-12 score was associated with increased risk of dementia death in an age-adjusted model (GHQ-12 score of 1-3: HR, 1.44 [95% CI, 1.17-1.78]; GHQ-12 score of 4-12: HR, 1.74 [95% CI, 1.36-2.22]; P value for trend, Ͻ.001). Adding all remaining covariates (sex, OSC, parental OSC, age at leaving full-time education, current smoking, alcohol consumption, and existing CVD and diabetes) led to some attenuation of effect but statistical significance at conventional levels was retained (GHQ-12 score of 1-3: HR, 1.27 [95% CI, 1.00-1.61]; GHQ-12 score of 4-12: HR, 1.56 [95% CI, 1.17-2.07]; P value for trend, .005). In the Figure we relate 7 categories of GHQ score to dementia death to provide more detailed insight into the shape of the relationship. There was evidence of a dose-response effect (P value for trend, .001). Excluding individuals with any missing data (sample n=57 716; 361 dementia deaths) or dementia deaths within 5 years (sample n=72 926; 310 dementia deaths)-the latter to explore reverse causality-did not affect our results.
Comment.
We found an association between elevated psychological distress and an increased risk of dementia death in a large general population sample of apparently dementiafree adults, which remained after adjustment for age, sex, OSC, education, alcohol use, smoking, and existing CVD and diabetes. Cardiovascular risk factors have been linked
